Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Current Opinion in Immunology|October 1, 1995
New tumor antigens recognized by T cellsB Van den Eynde, V G BrichardEuropean Journal of Immunology|March 1, 1995
Individual differences in the orientation of the cytolytic T cell response against mouse tumor P815V G Brichard, G Warnier, A Van Pel, et al.European Journal of Immunology|January 1, 1996
A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytesV G Brichard, J Herman, A Van Pel, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1996
Isolation of tyrosinase-specific CD8+ and CD4+ T cell clones from the peripheral blood of melanoma patients following in vitro stimulation with recombinant vaccinia virusC Yee, M J Gilbert, S R Riddell, et al.The Journal of Experimental Medicine|March 1, 1996
A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V geneY Guilloux, S Lucas, V G Brichard, et al.International Journal of Cancer|December 22, 1999
A tyrosinase peptide presented by HLA-B35 is recognized on a human melanoma by autologous cytotoxic T lymphocytesS Morel, A Ooms, A Van Pel, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2016
Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT)P Saiag, R Gutzmer, P A Ascierto, et al.ESMO Open|November 16, 2016
Safety and immunogenicity of the PRAME cancer immunotherapeutic in metastatic melanoma: results of a phase I dose escalation studyR Gutzmer, L Rivoltini, E Levchenko, et al.Pageof 1